-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Oppenheimer Adjusts Caribou Biosciences Price Target to $32 From $36, Maintains Outperform Rating

Oppenheimer Adjusts Caribou Biosciences Price Target to $32 From $36, Maintains Outperform Rating

MT Newswires · 03/10/2023 03:27